Mexico Enzyme Replacement Therapy Market Size & Outlook
Related Markets
Mexico enzyme replacement therapy market highlights
- The Mexico enzyme replacement therapy market generated a revenue of USD 36.0 million in 2024 and is expected to reach USD 58.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 8.5% from 2025 to 2030.
- In terms of segment, imiglucerase was the largest revenue generating product in 2024.
- Imiglucerase is the most lucrative product segment registering the fastest growth during the forecast period.
Enzyme replacement therapy market data book summary
| Market revenue in 2024 | USD 36.0 million |
| Market revenue in 2030 | USD 58.4 million |
| Growth rate | 8.5% (CAGR from 2025 to 2030) |
| Largest segment | Imiglucerase |
| Fastest growing segment | Imiglucerase |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Imiglucerase, Agalsidase Beta, Taliglucerase, Velaglucerase Alfa, Laronidase, Alglucosidase Alfa, Galsulfase, Idursulfase, Pancreatic Enzymes, Pegademase |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.3% of the global enzyme replacement therapy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. enzyme replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 607.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Enzyme Replacement Therapy Market Scope
Enzyme Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Recordati | View profile | 1001-5000 | Lebanon, New Jersey, United States, North America | http://www.recordati.it |
| Janssen | View profile | 10001+ | Beerse, Antwerpen, Belgium, Europe | https://www.janssen.com/ |
| Alexion Pharmaceuticals | View profile | 1001-5000 | Cheshire, Connecticut, United States, North America | https://alexion.com |
| Shire Plc (Takeda Pharmaceuticals) | View profile | - | - | - |
| Actelion Pharmaceuticals | View profile | - | - | - |
| Allergan PLC | View profile | - | - | - |
| Amicus Therapeutics Inc | View profile | 517 | 47 Hulfish Street, Princeton, NJ, United States, 08542 | https://www.amicusrx.com |
| Horizon Pharma | View profile | 1001-5000 | Northbrook, Illinois, United States, North America | https://www.horizontherapeutics.com |
| Biomarin Pharmaceutical Inc | View profile | 3401 | 770 Lindaro Street, San Rafael, CA, United States, 94901 | https://www.biomarin.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Mexico enzyme replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enzyme replacement therapy market will help companies and investors design strategic landscapes.
Imiglucerase was the largest segment with a revenue share of 21.94% in 2024. Horizon Databook has segmented the Mexico enzyme replacement therapy market based on imiglucerase, agalsidase beta, taliglucerase, velaglucerase alfa, laronidase, alglucosidase alfa, galsulfase, idursulfase, pancreatic enzymes, pegademase covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Mexico enzyme replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico enzyme replacement therapy market databook
-
Our clientele includes a mix of enzyme replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico enzyme replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into Mexico enzyme replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico enzyme replacement therapy market size, by product, 2018-2030 (US$M)
Mexico Enzyme Replacement Therapy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
